Z-L-aspartic acid β-tert-butyl ester dicyclohexylammonium salt
Need Assistance?
  • US & Canada:
    +
  • UK: +

Z-L-aspartic acid β-tert-butyl ester dicyclohexylammonium salt

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
CBZ-Amino Acids
Catalog number
BAT-000472
Molecular Formula
C16H21NO6·C12H23N
Molecular Weight
504.67
Synonyms
Z-L-Asp(OtBu)-OH DCHA; N-Cbz-L-aspartic acid 4-tert-butyl ester DCHA; Cbz-L-aspartic acid 4-tert-butyl ester DCHA; Cbz-L-Aspartic 4-tert-butyl ester DCHA
Related CAS
5545-52-8 (free base)
Appearance
White to off-white powder
Purity
≥ 98% (HPLC)
Melting Point
125-130 °C
Storage
Store at 2-8 °C

Z-L-aspartic acid β-tert-butyl ester dicyclohexylammonium salt, a versatile chemical compound, finds frequent application in peptide synthesis and biochemical research. Here are four key applications of this compound:

Peptide Synthesis: Essential in peptide synthesis, this compound acts as a protected amino acid derivative, safeguarding the functional groups of aspartic acid throughout the coupling process. This ensures the production of high-purity peptide chains, crucial for biological investigations and advancements in therapeutics.

Enzyme Research: In the realm of biochemical explorations, Z-L-aspartic acid β-tert-butyl ester dicyclohexylammonium salt serves as a valuable tool for studying enzyme-substrate interactions. By incorporating this compound into substrates, researchers can delve into how enzymes detect and process specific moieties, enhancing our understanding of enzyme mechanisms and aiding in the design of potential enzyme inhibitors for therapeutic use.

Drug Development: Within the pharmaceutical domain, this compound proves to be invaluable for formulating and synthesizing novel drugs. Acting as a foundational component for peptide-based drug development, it imparts stability and specificity to drug design, potentially leading to the discovery of new treatments for various conditions, including cancer and metabolic disorders.

Bioconjugation: Embraced in bioconjugation methodologies, Z-L-aspartic acid β-tert-butyl ester dicyclohexylammonium salt facilitates the attachment of peptides to larger biomolecules. This capability enables the creation of peptide-conjugated antibodies, nanoparticles, and other targeted delivery systems, crucial for diagnostic imaging, targeted therapy, and other cutting-edge biomedical applications.

Online Inquiry
Verification code
Inquiry Basket